Professor Mats Brittberg
Professor Mats Brittberg is currently a member of the Cartilage Research Unit, within the Department of Orthopedics Surgery, at the University of Gothenburg and an orthopedic surgeon at the Kungsbacka Hospital, Sweden. His research has been focused on cartilage repair and with the main focus on cartilage regeneration with autologous chondrocytes. He has been on the board of TESI (Tissue engineering Society International) and has been the chair of the Cartilage Committee of ESSKA 2006-08. Since 1997, he has worked with ICRS (International Cartilage Regeneration and Joint Repair Society), as Secretary, Vice-president and President (2006-2008), and Past-President (2008-2009). Since January 2013, he has been the Editor-in-Chief of the journal CARTILAGE. He has received several accolades including ICRS Genzyme Lifetime Achievement Award in cartilage research, the United Kingdom Cartilage Club and Shetty-Kim Research Foundation’s scientific Award, Canterbury Christ Church University, and UK Cartilage Club’s Lifetime award in cartilage research. He has also recently received the Lifetime Achievement award from Joint Preservation Congress in Warsaw, Poland.
Professor Emeritus Lars Peterson
Lars Peterson has been a hugely influential figure in Orthopedics and Sports Medicine in Sweden and worldwide. Peterson was a pioneer of the autologous chondrocyte transplantation procedure for the repair of articular cartilage. Throughout his long career, Peterson has been a world-renowned orthopedic surgeon, was appointed Professor of Orthopaedic Surgery at the University of Gothenburg, and served as head physician of the Swedish national team for both ice hockey and soccer. For 38 years, Lars Peterson has been a member of the Sports Medical Committee of FIFA and a founding member of F-MARC (FIFA Medical Assessment and Research Center). In addition, he was one of the founders of ICRS (International Cartilage Regeneration and Joint Repair Society). He served as president from 2001 to 2002.
Peterson has received many accolades throughout his long career, including being the elected member of The Hall of Fame of the American Orthopaedic Society of Sports Medicine in 2007. He has published more than 200 articles, reviews, and book chapters.
Dr Sven Grekevik
Sven completed medical studies at Lund University and specialist training with Sahlgrenska University Hospital. He serves as a consultant orthopedic surgeon for Varberg Hospital as well as within private practice in Falkenberg. Additionally, Sven has participated in Health Technology Assessment for the Southern Healthcare Region with Region Skåne and serves on the board for Private Orthopedic Association.
Anders Lundgren - Ph.D Chalmers University of Technology
Anders Lundgren holds an engineer degree from Linköping University within technical biotechnology and a
PhD from the University of Gothenburg. Anders has long and extensive experience in the technology field Cline Scientific operates within, both from the academic and the business sector. Today, Anders has a postdoc
postion at the University of Vienna, in collaboration with Chalmers University of Technology
under the direction of Professor Fredrik Höök.
Anders is co-inventor of Cline Scientific´s surface gradient technology.
At Cline Scientific Anders serves as scientific and technical advisor and engage in new product development.
Stephen Minger, Ph.D
Dr Stephen Minger was appointed the Global Director for Research and Development for Cell Technologies at GE Healthcare in September 2009. Stephen received his PhD in Pathology (Neurosciences) in 1992 from the Albert Einstein College of Medicine in New York City. After post-doctoral work in central nervous system gene therapy, neural transplantation and neural stem cell biology at UCSD with Professor Fred “Rusty” Gage, he moved to the UK in 1996 and was appointed a Lecturer in Biomolecular Sciences at King's College London in 1998. He was appointed a Senior Lecturer in Stem Cell Biology in 2005 and was the Director of the Stem Cell Biology Laboratory from 2002 until joining GE Healthcare in 2009.
Peter Ehrenheim
Mr. Peter Ehrenheim has a long successful career in the Life Sciences sector. He received his Master of Science in Mechanical Engineering from the Royal Institute of Technology in Stockholm, Sweden in 1980.
He served as Chief Executive Officer and President of Life Sciences at GE Healthcare Limited from March 2006 to April, 2011. He served as the President of Protein Separations of GE Healthcare Bio-Sciences between 2004 and 2006. Prior to GE he had a long career at Amersham, where he in the end served as President of Protein separations, supervising a number of acquisitions that strengthened its leadership position in the industry. He served various positions within the Protein Separations business since joining Amersham in 1983, including three years as the U.S. Head of Manufacturing and Head of the Industrial Molecular Biology business. He served in Production Operations at Cleveland, Milwaukee and Pittsburgh sites.
Current and previous board positions:
Chairman of the board in Boule Diagnostics AB, Boardmember in Biotage AB, Chairman in Sophion Bioscience Boardmemeber in Nanologica AB, Advisor at Berkeley Lights in California
Mattias Berglin - Ass. Professor Gothenburg University
Mattias Berglin holds a PhD from Chalmers University of Technology within biopolymertechnology. Since 2008, Mattias is assistant professor at the University of Gothenburg and now partly employed at SP (Science Partner) and partly on the University of Gothenburg.
Mattias is co-inventor of Cline Scientific´s surface gradient technology and engage is the company´s board of advisors.
Michael Andäng, Ph.D
Leader of the research group "Biophysics of Stem Cell and Tissue Growth" at the Department of Immunology, Genetics and Pathology at Uppsala University. The research interests concern mechanisms that affect stem cell and cancer cell behavior such as growth, differentiation and migration. Co-founder of Liv Diagnostics AB and scientific advisor to Cline Scientific.
Theresa Vincent - Ph.D
Leader of the research group "Cancer and Stem Cell Therapy" at the Department of Immunology, Genetics and Pathology at Uppsala University. Theresa also works at Cornell Medical College and has research interest in processes that control ribosomal biogenesis, migration and spread of cancer cells focusing on breast cancer. Co-founder of Liv Diagnostics AB and scientific advisor to Cline Scientific.
Petra Szeszula, Ph.D
Petra has extensive experience in research work, as well as biotechnology research and development. For much of her career she has focused on molecular biology, cell biology and cancer research at BIOPHARM a.s. (Czech Republic), Karolinska Institutet and CEITEC (Central European Institute of Technology in the Czech Republic and at Liv Diagnostics AB)